Skip to Content
Merck
CN
Search Within

W401404

Applied Filters:
Keyword:'W401404'
Showing 31-38 of 38 results for "W401404" within Papers
A E Elaine van Ommen Kloeke et al.
Ecotoxicology (London, England), 21(4), 1084-1093 (2012-02-09)
Natural toxins, such as isothiocyanate (ITC), are harmful secondary metabolites produced by plants. Many natural toxins occur in commercial crops, yet their possible negative repercussions on especially non-target soil organisms are largely unknown. This study examined life-history and gene transcriptional
Juyoung Lee et al.
Journal of the science of food and agriculture, 95(11), 2244-2251 (2014-10-02)
Glucosinolates are abundant in Brassicaceae vegetables, and they are degraded into various organic breakdown products (BPs) (R-CN, -NCS and -SCN) by myrosinase when plant tissues are damaged. This study was designed to investigate whether these BPs could be broken further
Parul Gupta et al.
BMC medicine, 10, 80-80 (2012-07-25)
HER2 is an oncogene, expression of which leads to poor prognosis in 30% of breast cancer patients. Although trastuzumab is apparently an effective therapy against HER2-positive tumors, its systemic toxicity and resistance in the majority of patients restricts its applicability.
Phenethyl isothiocyanate regulates inflammation through suppression of the TRIF-dependent signaling pathway of Toll-like receptors.
Park HJ, Kim SJ, Park SJ, et al.
Life Sciences, 92(13), 793-798 (2013)
Sarah Weiler et al.
Molecular cancer, 14, 30-30 (2015-02-04)
Members of the inhibitor of DNA-binding (ID) family of helix-loop-helix proteins have been causally implicated in the pathogenesis of several types of B-cell lineage malignancy, either on the basis of mutation or by altered expression. B-cell chronic lymphocytic leukemia encompasses
Wen-jing Wu et al.
Biochemical pharmacology, 85(4), 486-496 (2012-12-12)
Platinum (Pt)-based chemotherapy is an important regimen in the clinical treatment of cancer, but development of drug resistance presents a major challenge. One key mechanism involved in resistance to Pt drugs is the decrease of intracellular Pt due to the
Pierre-Alexandre Lallement et al.
FEBS letters, 589(1), 37-44 (2014-12-03)
Glutathionyl-hydroquinone reductases (GHRs) catalyze the deglutathionylation of quinones via a catalytic cysteine. The two GHR genes in the Populus trichocarpa genome, Pt-GHR1 and Pt-GHR2, are primarily expressed in reproductive organs. Both proteins are localized in plastids. More specifically, Pt-GHR2 localizes
L Truitt et al.
Oncogenesis, 3, e122-e122 (2014-10-21)
Chronic myelogenous leukemia (CML) is maintained by a minor population of leukemic stem cells (LSCs) that exhibit innate resistance to tyrosine kinase inhibitors (TKIs) targeting BCR-ABL. Innate resistance can be induced by secreted bone marrow stromal cytokines and growth factors
Page 2 of 2